Assay News and Research

RSS
Is monkeypox a global public-health emergency?

Is monkeypox a global public-health emergency?

20 Jul 2022
High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

20 Jul 2022
What is the prevalence of orthopoxviruses across different populations?

What is the prevalence of orthopoxviruses across different populations?

20 Jul 2022
Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

20 Jul 2022
Neutralizing activity of skin-patch delivered subunit vaccine against SARS-CoV-2 variants

Neutralizing activity of skin-patch delivered subunit vaccine against SARS-CoV-2 variants

20 Jul 2022
Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

20 Jul 2022
Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

Study shows Omicron BA.4/5 infection triggers highly cross-reactive neutralizing antibodies

20 Jul 2022
CDC experts update on monkeypox in the United States

CDC experts update on monkeypox in the United States

19 Jul 2022
Identifying a core human microbiome

Identifying a core human microbiome

19 Jul 2022
Researchers report genomic profiling from more than 110,000 tumors

Researchers report genomic profiling from more than 110,000 tumors

19 Jul 2022
Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

18 Jul 2022
Researchers develop a rapid, specific, and accurate RT-qPCR-based method to detect and distinguish between Omicron sublineages

Researchers develop a rapid, specific, and accurate RT-qPCR-based method to detect and distinguish between Omicron sublineages

18 Jul 2022
The characteristics of circulating T follicular helper cells in COVID-19 patients across mild to severe disease

The characteristics of circulating T follicular helper cells in COVID-19 patients across mild to severe disease

18 Jul 2022
Cytokine-based cancer immunotherapy: current progress and future prospects

Cytokine-based cancer immunotherapy: current progress and future prospects

From Sino Biological Inc. 18 Jul 2022
Novel nanoligomer approach to treat severe COVID-19

Novel nanoligomer approach to treat severe COVID-19

17 Jul 2022
Tokyo Tech researchers develop the first synthetic mechanosensitive potassium channel

Tokyo Tech researchers develop the first synthetic mechanosensitive potassium channel

15 Jul 2022
Researchers identify fusion peptide-specific monoclonal antibodies with broad neutralizing activity

Researchers identify fusion peptide-specific monoclonal antibodies with broad neutralizing activity

14 Jul 2022
The interaction between SARS-CoV-2 and influenza A during coinfection

The interaction between SARS-CoV-2 and influenza A during coinfection

14 Jul 2022
Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

13 Jul 2022
Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

13 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback